The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
An Updated Review On:Liposomes as Drug Delivery System
Open accessAbstract
Liposomes are most placed acquiring in pharma industries and very useful in the various drug delivery system used to target the drug to particular tissue. Because of structural similarity between lipid bilayer (two layer) and cell membrane, liposome can easily penetrate effectively deliver drug to such that a free drug would not easily penetrate. Liposomes can be also encapsulate in both hydrophilic and hydrophobic materials, and are utilized as drug carriers in drug delivery. This technology is very useful for the treatment of certain diseases. Now a day’s most of the researcher attraction and interest will increase for that technology i.e. Liposomes. Main object of this review this technology i.e. Liposomes very useful in certain disease and easily prepare and also give various advantages other than. Liposomes are highly biocompatible, with applications ranging from delivering enzymes, antibacterial, antiviral drugs, antiparasite drugs, transdermal transporters, fungicides, diagnostic tools and adjuvant for vaccines. This paper mainly focus on exclusively scalable techniques and also focus on strength, respectively, limitations in respect to industrial applicability and regulatory requirements concerning liposomal drug formulations based on FDA and EMEA documents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Nanoliposomes form a protective barrier that protects molecules from degradation by enzymes in the mouth and stomach, digestive juices, bile acid, and intestinal microorganisms.
“NL forms a protective barrier that protects the molecules from degradation by enzymes in the mouth and stomach, digestive juices, bile acid, and intestinal microorganisms [41,42].”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [41]
Citations
Cites
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Flagged first, then by citations
Cited by
Sorted by citations
Alzheimer's Disease: Treatment Strategies and Their Limitations.
Passeri, E., Elkhoury, K., Morsink, M., Broersen, K., Linder, M., Tamayol, A., Malaplate, C., Yen, F. T., & Arab-Tehrany, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213954 · Cited by 689
Metadata
- Authors
- Sharma, D., Ali, A. A. E., & Trivedi, L. R.
- ORCID
- Sharma, D.
- Venue
- Pharmatutor
- Publisher
- PharmaTutor Edu Labs
- Published
- 2018-01-02
- Volume
- 6
- Issue
- 2
- Pages
- 50
- ISSN
- 2347-7881 (ISSN-L)
- 2394-6679
- OpenAlex
- W2787505967
- Cited by
- 81
- References
- 1
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 13 · 2023: 6 · 2022: 14 · 2021: 19 · 2020: 7 · 2019: 4 · 2018: 2
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc
- Locations
- Pharmatutor (publishedVersion, cc-by-nc)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- liposomes, drug delivery systems, lipid bilayers, drug encapsulation, biocompatibility, liposomal drug formulation, scalable fabrication, regulatory requirements, FDA guidance, transdermal drug delivery, vaccine adjuvants, antiviral agents, antiparasitic drugs, antifungal agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review